Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery

Mosely, S.I.S., Prime, J.E., Sainson, R.C.A. et al. (21 more authors) (2017) Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery. Cancer Immunology Research, 5 (1). pp. 29-41. ISSN 2326-6066

Abstract

Metadata

Authors/Creators:
  • Mosely, S.I.S.
  • Prime, J.E.
  • Sainson, R.C.A.
  • Koopmann, J.-O.
  • Wang, D.Y.Q.
  • Greenawalt, D.M.
  • Ahdesmaki, M.J.
  • Leyland, R.
  • Mullins, S.
  • Pacelli, L.
  • Marcus, D.
  • Anderton, J.
  • Watkins, A.
  • Ulrichsen, J.C.
  • Brohawn, P.
  • Higgs, B.W.
  • McCourt, M.
  • Jones, H.
  • Harper, J.A.
  • Morrow, M.
  • Valge-Archer, V.
  • Stewart, R.
  • Dovedi, S.J.
  • Wilkinson, R.W.
Copyright, Publisher and Additional Information: © 2017 American Association for Cancer Research. This is an author produced version of a paper subsequently published in Cancer Immunology Research. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: 1 January 2017
  • Published (online): 6 December 2016
  • Accepted: 11 November 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Neuroscience (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 01 Mar 2017 15:51
Last Modified: 06 Dec 2017 01:38
Published Version: https://doi.org/10.1158/2326-6066.CIR-16-0114
Status: Published
Publisher: American Association for Cancer Research
Refereed: Yes
Identification Number: https://doi.org/10.1158/2326-6066.CIR-16-0114
Related URLs:

Share / Export

Statistics